Informations générales (source: ClinicalTrials.gov)
SIOPEN BIOPORTAL, an International Registry Linked to a Virtual Biobank for Patients with Peripheral Neuroblastic Tumours (BIOPORTAL)
Interventional
N/A
Institut Curie (Voir sur ClinicalTrials)
novembre 2023
novembre 2038
27 mars 2025
The SIOPEN BIOPORTAL is a prospective non-therapeutic multi-centre international study
aimed at developing an international Registry linked to a Virtual Biobank for all the
patients with peripheral neuroblastic tumor within countries of the SIOPEN network. The
overall aim of this study is to provide a GDPR-compliant framework to collect basic
clinical annotations, biological and genetic features and information about the location
on biospecimens for all the patients with a peripheral neuroblastic tumor including
neuroblastoma, ganglioneuroblastoma and ganglioneuroma in the SIOPEN network.
This study will support data and sample management and intensify cross-borders data and
sample sharing fostering translational and clinical research. The post-hoc hypothesis
formulated based on the data generated in this study will be used as statistical basis
for future precision medicine programs based on improved biological characterization,
patient stratification and therapeutic management.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT CURIE | 10/04/2025 13:12:09 | Contact (sur clinicalTrials) | |||
| CLCC INSTITUT GUSTAVE ROUSSY | Nathalie GASPAR | 24/05/2024 09:45:47 | Contacter | ||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| AP-HP - Hôpital Armand Trousseau-La Roche Guyon | Arnaud PETIT, MD | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Léon Bérard - 69373 - Lyon - France | Benoît DUMONT, MD | Contact (sur clinicalTrials) | |||
| Centre Oscar Lambret - 59020 - Lille - France | Anne-Sophie DEFACHELLES, MD | Contact (sur clinicalTrials) | |||
| Chr Nantes - 44093 - Nantes - France | Estelle THEBAUD, MD | Contact (sur clinicalTrials) | |||
| Chru Brest - 29609 - Brest - France | Liana CARAUSU, MD | Contact (sur clinicalTrials) | |||
| CHU Amiens - 80054 - Amiens - France | Antoine GOURMEL, MD | Contact (sur clinicalTrials) | |||
| Chu Angers - 49033 - Angers - France | Stéphanie PROUST, MD | Contact (sur clinicalTrials) | |||
| CHU CAEN - Fédération de cancérologie - niveau 21 - 14033 - Caen - France | Damien BODET, MD | Contact (sur clinicalTrials) | |||
| CHU D'Estaing de CLERMONT FERRAND - 63003 - Clermont-Ferrand - France | Justyna KANOLD, MD | Contact (sur clinicalTrials) | |||
| Chu Grenoble - 38045 - Grenoble - France | Cécile PERRET, MD | Contact (sur clinicalTrials) | |||
| Chu Hopital Sud - 35056 - Rennes - France | Sophie TAQUE, MD | Contact (sur clinicalTrials) | |||
| CHU NANCY- Hôpital d'Enfants - 54500 - Vandœuvre-lès-Nancy - France | Ludovic MANSUY, MD | Contact (sur clinicalTrials) | |||
| CHU NICE - 06202 - Nice - France | Joy BENADIBA, MD | Contact (sur clinicalTrials) | |||
| Chu Reims - 51092 - Reims - France | Claire PLUCHART, MD | Contact (sur clinicalTrials) | |||
| DIJON Hôpital d'enfants - 21079 - Dijon - France | Claire BRIANDET, MD | Contact (sur clinicalTrials) | |||
| Hôpital Arnaud de Villeneuve - 34295 - Montpellier - France | Tasnime AKBARALY, MD | Contact (sur clinicalTrials) | |||
| Hôpital Charles NICOLLE - 76031 - Rouen - France | Aude MARIE CARDINE, MD | Contact (sur clinicalTrials) | |||
| Hôpital Clocheville - 37044 - Tours - France | Julien LEJEUNE, MD | Contact (sur clinicalTrials) | |||
| Hôpital d'Enfants de la Timone - 13385 - Marseille - France | Carole COZE, MD | Contact (sur clinicalTrials) | |||
| Hôpital des enfants - 33076 - Bordeaux - France | Julie TANDONNET, MD | Contact (sur clinicalTrials) | |||
| Hôpital des Enfants - 70034 - Toulouse - France | Marion GAMBART, MD | Contact (sur clinicalTrials) | |||
| Hôpital Hautepierre-CHU Strasbourg - 67098 - Strasbourg - France | Sarah JANNIER, MD | Contact (sur clinicalTrials) | |||
| Hôpital Jean Bernard - 86021 - Poitiers - France | Chrystelle DUPRAZ, MD | Contact (sur clinicalTrials) | |||
| Hôpital Jean Minjoz - 25030 - Besançon - France | Veronique LAITHIER, MD | Contact (sur clinicalTrials) | |||
| Hôpital Nord - 42055 - Saint-Étienne - France | Claire BERGER, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
I-1. Patients with PNT: ganglioneuroma or ganglioneuroblastoma or neuroblastoma, I-2. At
the time of initial diagnosis of neuroblastic tumour, or at relapse/progression if not
yet registered I-3. Written patient informed consent, or parents or legal representative
written informed consent and assent of the child, adolescent or young adult
Non-Inclusion Criteria:
R-1. (Adult) Patients with olfactory neuroblastoma R-2. Central nervous system (CNS)
neuroblastoma (as per the WHO classification)
I-1. Patients with PNT: ganglioneuroma or ganglioneuroblastoma or neuroblastoma, I-2. At
the time of initial diagnosis of neuroblastic tumour, or at relapse/progression if not
yet registered I-3. Written patient informed consent, or parents or legal representative
written informed consent and assent of the child, adolescent or young adult
Non-Inclusion Criteria:
R-1. (Adult) Patients with olfactory neuroblastoma R-2. Central nervous system (CNS)
neuroblastoma (as per the WHO classification)